Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,389
datasets available to search
ShareScore release 0.9.0
Dataset results
1,389 results for “bladder cancer”
Bladder Sparing Treatment of Tislelizumab, Gemcitabine and Cisplatin for Patients With PD-L1 Positive Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT05401279. IPD Sharing: NO. Countries: 1. Publications: 0.
Bladder Cancer Detection Using Convolutional Neural Networks
ClinicalTrials.gov study NCT05193656. IPD Sharing: NO. Countries: 1. Publications: 0.
Chemotherapy Combined With Tislelizumab as Bladder Sparing Option for Patients With Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT04909775. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
ClinicalTrials.gov study NCT07309445. IPD Sharing: YES. Countries: 0. Publications: 0.
A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT03121768. IPD Sharing: YES. Countries: 1. Publications: 0.
Radical CystEctomy or RaDio-chEMotherapy as Preferred Treatment for invasivE blaDder Cancer
ClinicalTrials.gov study NCT07008833. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Surveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer Monitor
ClinicalTrials.gov study NCT04100733. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy
ClinicalTrials.gov study NCT03106610. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer
ClinicalTrials.gov study NCT02861196. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT05946369. IPD Sharing: NO. Countries: 1. Publications: 0.
Omega-3 Polyunsaturated Fatty Acids and Non-Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT04664816. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects
ClinicalTrials.gov study NCT04861584. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation
ClinicalTrials.gov study NCT07038928. IPD Sharing: YES. Countries: 1. Publications: 0.
Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer
ClinicalTrials.gov study NCT01824329. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multimodal Rehabilitation Program to Bladder Cancer Patients
ClinicalTrials.gov study NCT01329107. IPD Sharing: Not stated. Countries: 1. Publications: 0.
JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer
ClinicalTrials.gov study NCT05739071. IPD Sharing: NO. Countries: 1. Publications: 0.
Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT06441110. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
ClinicalTrials.gov study NCT07222488. IPD Sharing: YES. Countries: 4. Publications: 0.
Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery
ClinicalTrials.gov study NCT02944357. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
ClinicalTrials.gov study NCT00627432. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.